Ignoring issues in a sterile manufacturing plant can lead to big problems, like the $18 million-plus Baxter International will pay to resolve a federal criminal case and a civil matter over mold concerns at a plant in North Carolina.
Golf outings at top courses. Box suites at sporting events. A Los Angeles Lakers basketball camp. And the usual “lavish dinners.” They all figured into a $30 million California kickbacks settlement with Bristol-Myers Squibb.
In the first FDA settlement that turns on cancer-drug survival data, Roche’s Genentech unit and OSI Pharmaceuticals agreed to pay $67M to settle claims that they misled doctors about Tarceva’s effectiveness.